A detailed history of Ashton Thomas Securities, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 45 shares of INCY stock, worth $3,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Holding current value
$3,408
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$57.33 - $68.61 $2,579 - $3,087
45 New
45 $2.98 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.